Profusa Inc. Ordinary Shares PFSA 深 滬
等待開盤 09-24 09:30:00 美东时间
0.3289
+0.003
+0.80%
華盛通- 最 高0.3351
- 今 開0.3264
- 成交量 50.49万股
- 最 低 0.3252
- 昨 收 0.3263
- 總市值 1186.96万
- 52周最高 2.40
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.265
- 委 比 -47.83%
- 總股本 3608.89万
- 歷史最高 2.40
- 量 比 0.35
- 振 幅 3.03%
- 歷史最低 0.265
- 每 手 1
- 風險率
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Profusa Faces Nasdaq Listing Compliance Challenges
Profusa ( ($PFSA) ) has shared an update. On September 11, 2025, Profusa, Inc. ...
09-17 05:50
Profusa shares are trading higher after the company announced the adoption of NVIDIA technology to power an AI-driven insight portal for continuous biochemistry monitoring.
Profusa shares are trading higher after the company announced the adoption of N...
09-11 20:34
Profusa Approves $100 Million Equity Line of Credit
Profusa ( ($PFSA) ) just unveiled an update. On August 29, 2025, Profusa Inc. h...
09-05 05:49
Profusa Adds Head of Vascular Surgery Department at AZ Sint Blasius Hospital, Belgium to Growing Customer Base
Profusa, a digital health company, collaborates with Dr. Koen Deloose, a leading vascular surgeon in Belgium, to advance CLTI treatment using its Lumee Oxygen monitoring system. The partnership aims to improve patient outcomes through innovative technologies and personalized care.
09-04 12:30
Profusa to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Profusa, Inc., a digital health company specializing in continuous biochemical monitoring, announced that CEO Ben Hwang will present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8–10, 2025, at the Lotte New York Palace Hotel. Dr. Hwang’s presentation will be available on demand starting September 5, 2025, at 7:00am ET for registered investors. The company, based in Berkeley, Calif., develops tissue-integrated senso...
09-02 20:05
Profusa Announces Commercial and Clinical Collaboration with Head of Angiography, Medical University of Graz, Austria
Profusa, Inc. has announced a collaboration with Prof. Dr. Marianne Brodmann at the Medical University of Graz, Austria. Prof. Brodmann will adopt and integrate Profusa's Lumee Oxygen platform technology into her practice, involving approximately 1,500 annual vascular procedures. The collaboration aims to enhance patient monitoring and clinical outcomes while expanding the platform's market reach.
08-27 12:45
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Invivyd (NASDAQ:IVVD) stock increased by 132.3% to $1.3 during Tuesday...
08-26 20:09
Why Serina Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket
Shares of Serina Therapeutics Inc (NYSE:SER) rose sharply in pre-market trading...
08-26 17:52
Profusa Appoints New CFO and Lead Director
Profusa ( ($PFSA) ) has shared an update. On August 19, 2025, Profusa announced...
08-20 04:57
Profusa Announces Nasdaq Listing and Growth Plans
Profusa ( ($PFSA) ) has provided an update. On August 6, 2025, Profusa, Inc. an...
08-08 04:56
